2020

Remove inpatient-vaccines
article thumbnail

Episode 548: Why was the quadrivalent meningococcal vaccine used as a control for a COVID-19 vaccine?

Pharmacy Joe

In this episode, I’ll discuss why the quadrivalent meningococcal vaccine was used as a control for a COVID-19 vaccine. Episode 548: Why was the quadrivalent meningococcal vaccine used as a control for a COVID-19 vaccine? The delivery of this spike protein then causes the immunogenicity to the virus to develop.

article thumbnail

Episode 535: Tetanus immune globulin

Pharmacy Joe

Recommendations on who should receive tetanus immune globulin as post-exposure prophylaxis are those patients with less than 3 or an unknown number of tetanus vaccines and a dirty/contaminated wound. If the patient is also receiving a tetanus vaccine, separate syringes and different anatomical sites must be used for each injection.

article thumbnail

Episode 565: Available Safety and Efficacy Data of the BNT162b2 mRNA Covid-19 Vaccine

Pharmacy Joe

In this episode, I’ll discuss the available safety and efficacy data of Pfizer’s Covid-19 vaccine. A fact sheet for the vaccine is available from the FDA here. 43,548 patients were divided evenly between the vaccine and placebo groups. The vaccine overall was 95% effective.